• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVR

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

6.26% ! $5.60
Market Cap $86.68M  !

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



Filters [Clear]
  • Price Sensitive: Yes
AVR Results for the Second Quarter of 2025PRICE SENSITIVE12/08/25 download Created with Sketch. 280.95KB
AVR Quarterly Results Announcement and SEC Form 10-QPRICE SENSITIVE12/08/25 download Created with Sketch. 957.73KB
AVR Results for the First Quarter of 2025PRICE SENSITIVE14/05/25 download Created with Sketch. 272.75KB
AVR Quarterly Results Announcement and SEC Form 10-QPRICE SENSITIVE14/05/25 download Created with Sketch. 635.04KB
AVR SEC Form 10-K/APRICE SENSITIVE30/04/25 download Created with Sketch. 469.48KB
AVR Anteris Reports One-Year Patient Outcomes for DurAVR THVPRICE SENSITIVE21/03/25 download Created with Sketch. 262.29KB
AVR 2024 Financial Results and Corporate UpdatePRICE SENSITIVE13/03/25 download Created with Sketch. 301.88KB
AVR Annual Report to shareholdersPRICE SENSITIVE13/03/25 download Created with Sketch. 1.39MB
AVR Director Appointment/ResignationPRICE SENSITIVE06/03/25 download Created with Sketch. 212.79KB
AVR Partial Exercise of Option and End of Stabilisation PeriodPRICE SENSITIVE15/01/25 download Created with Sketch. 172.76KB
AVR Closing of US IPO, NASDAQ listing, ASX Listing of CDIsPRICE SENSITIVE17/12/24 download Created with Sketch. 173.8KB
AVR Reinstatement to QuotationPRICE SENSITIVE17/12/24 download Created with Sketch. 518.55KB
AVR ATGC Announces Pricing of US Initial Public OfferingPRICE SENSITIVE13/12/24 download Created with Sketch. 177.73KB
AVR Confirmation of Implementation TimetablePRICE SENSITIVE13/12/24 download Created with Sketch. 170.59KB
AVR ATGC Announces Launch of U.S. Initial Public OfferingPRICE SENSITIVE10/12/24 download Created with Sketch. 178.14KB
AVR Suspension from QuotationPRICE SENSITIVE05/12/24 download Created with Sketch. 262.04KB
AVR ATGC files Registration Statement for Proposed US IPOPRICE SENSITIVE25/11/24 download Created with Sketch. 183.26KB
AVR Approval-Supplementary Scheme Booklet, New Schemes TimetablePRICE SENSITIVE12/11/24 download Created with Sketch. 793.24KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/24 download Created with Sketch. 381.03KB
AVR Anteris Secures Bridging FacilityPRICE SENSITIVE31/10/24 download Created with Sketch. 265.07KB
AVR Update on Schemes, Nasdaq listing and US IPOPRICE SENSITIVE30/09/24 download Created with Sketch. 249.98KB
AVR Court Approval to Hold Scheme Meetings & Booklet RegisteredPRICE SENSITIVE02/09/24 download Created with Sketch. 3.76MB
AVR Half Yearly Report and AccountsPRICE SENSITIVE22/08/24 download Created with Sketch. 1.11MB
AVR Plan to Pursue Re-domiciliation, Nasdaq listing and US IPOPRICE SENSITIVE13/08/24 download Created with Sketch. 869.43KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/24 download Created with Sketch. 365.33KB
AVR Capital RaisePRICE SENSITIVE24/07/24 download Created with Sketch. 7.17MB
AVR Trading HaltPRICE SENSITIVE22/07/24 download Created with Sketch. 564.8KB
AVR Pause in tradingPRICE SENSITIVE22/07/24 download Created with Sketch. 115.09KB
AVR Anteris and v2vmedtech Announce Concept Lock for VClipPRICE SENSITIVE01/07/24 download Created with Sketch. 183.16KB
AVR AGM Chairman and CEO PresentationPRICE SENSITIVE29/05/24 download Created with Sketch. 7.14MB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE18/04/24 download Created with Sketch. 362.14KB
AVR Capital RaisePRICE SENSITIVE10/04/24 download Created with Sketch. 138.25KB
AVR Trading HaltPRICE SENSITIVE09/04/24 download Created with Sketch. 286.67KB
AVR Pause in tradingPRICE SENSITIVE09/04/24 download Created with Sketch. 116.02KB
AVR Updated 30-day DurAVR THV Clinical DataPRICE SENSITIVE12/03/24 download Created with Sketch. 195.95KB
AVR Preliminary Final ReportPRICE SENSITIVE28/02/24 download Created with Sketch. 1.29MB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 352.81KB
AVR Investor PresentationPRICE SENSITIVE09/01/24 download Created with Sketch. 2.53MB
AVR Update on Equity RaisingPRICE SENSITIVE15/12/23 download Created with Sketch. 176.71KB
AVR 30-day Haemodynamic Results from the DurAVR US EFS TrialPRICE SENSITIVE21/11/23 download Created with Sketch. 231.09KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 338.86KB
AVR Reinstatement to Official QuotationPRICE SENSITIVE26/10/23 download Created with Sketch. 86.42KB
AVR Capital RaisePRICE SENSITIVE26/10/23 download Created with Sketch. 209.83KB
AVR Positive Results from Interim Analysis of DurAVR EFS TrialPRICE SENSITIVE25/10/23 download Created with Sketch. 239.22KB
AVR Suspension from Official QuotationPRICE SENSITIVE25/10/23 download Created with Sketch. 594.08KB
AVR Trading HaltPRICE SENSITIVE23/10/23 download Created with Sketch. 613.94KB
AVR Anteris Completes DurAVR THV EFS EnrolmentPRICE SENSITIVE17/10/23 download Created with Sketch. 232.36KB
AVR Appendix 4D and Half Year Financial Report AnnouncementPRICE SENSITIVE25/08/23 download Created with Sketch. 182.9KB
AVR Appendix 4D and Half Year Financial ReportPRICE SENSITIVE25/08/23 download Created with Sketch. 714.97KB
AVR Exceptional Results in Second Valve-in-Valve CasePRICE SENSITIVE14/08/23 download Created with Sketch. 145.89KB
AVR Commencement of American Depository Receipt ProgramPRICE SENSITIVE09/08/23 download Created with Sketch. 164.44KB
AVR Montefiore enrolls Patients in US Early Feasibility StudyPRICE SENSITIVE09/08/23 download Created with Sketch. 208.28KB
AVR DurAVR first successful implantation Valve-in-ValvePRICE SENSITIVE31/07/23 download Created with Sketch. 155.23KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/07/23 download Created with Sketch. 305.43KB
AVR Latest Patient Group Show Best Results to Date at 30 DaysPRICE SENSITIVE13/06/23 download Created with Sketch. 177.4KB
AVR DurAVR THV Demonstrate Sustained Haemodynamics to 1 YearPRICE SENSITIVE09/06/23 download Created with Sketch. 177.46KB
AVR DurAVR Maintains Exceptional Results in New Patient CohortPRICE SENSITIVE31/05/23 download Created with Sketch. 151.62KB
AVR AGM Chairman Address and CEO PresentationPRICE SENSITIVE29/05/23 download Created with Sketch. 8MB
AVR FIH Results Presented at EuroPCR & Simultaneous PublicationPRICE SENSITIVE22/05/23 download Created with Sketch. 171.97KB
AVR Additional Patent for Heart Valve Replacement TechnologyPRICE SENSITIVE17/05/23 download Created with Sketch. 189.9KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE24/04/23 download Created with Sketch. 285.17KB
AVR Agreement to Develop New Heart Valve Repair DevicePRICE SENSITIVE19/04/23 download Created with Sketch. 233.95KB
AVR Patent for Transcatheter Heart Valve Replacement TechnologyPRICE SENSITIVE12/04/23 download Created with Sketch. 142.14KB
AVR Presentation at NWR Virtual Healthcare ConferencePRICE SENSITIVE21/03/23 download Created with Sketch. 3.68MB
AVR S&P DJI Announces March 2023 Quarterly RebalancePRICE SENSITIVE03/03/23 download Created with Sketch. 128.97KB
AVR Preliminary Final ReportPRICE SENSITIVE28/02/23 download Created with Sketch. 1.98MB
AVR Settlement of $35M Capital Raising TransactionPRICE SENSITIVE15/02/23 download Created with Sketch. 197.59KB
AVR FDA Grants Expanded Approval for the DurAVR EFSPRICE SENSITIVE09/02/23 download Created with Sketch. 193.17KB
AVR $35M Capital RaisePRICE SENSITIVE09/02/23 download Created with Sketch. 167.64KB
AVR Trading HaltPRICE SENSITIVE07/02/23 download Created with Sketch. 239.32KB
AVR Pause in TradingPRICE SENSITIVE07/02/23 download Created with Sketch. 116.79KB
AVR Proposed $50 Million Capital FacilityPRICE SENSITIVE06/02/23 download Created with Sketch. 242.67KB
AVR Trading HaltPRICE SENSITIVE02/02/23 download Created with Sketch. 598.29KB
AVR Pause in TradingPRICE SENSITIVE02/02/23 download Created with Sketch. 116.09KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 290.43KB
AVR DurAVR First in Human Study 12 Month ResultsPRICE SENSITIVE16/01/23 download Created with Sketch. 185.98KB
AVR FDA Approves Early Feasibility Study for DurAVR THV SystemPRICE SENSITIVE28/11/22 download Created with Sketch. 171.92KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE26/10/22 download Created with Sketch. 319.67KB
AVR Results Demonstrating Restoration of Normal Pre-Disease FlowPRICE SENSITIVE19/09/22 download Created with Sketch. 165.97KB
AVR Appendix 4D and Half Year Financial Report AnnouncementPRICE SENSITIVE24/08/22 download Created with Sketch. 174.21KB
AVR Appendix 4D and Half Year Financial ReportPRICE SENSITIVE24/08/22 download Created with Sketch. 620.54KB
AVR Appendix 4C Clarification and Upcoming MilestonesPRICE SENSITIVE27/07/22 download Created with Sketch. 176.33KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE25/07/22 download Created with Sketch. 317.11KB
AVR Update on First In Human DurAVR THV StudyPRICE SENSITIVE11/07/22 download Created with Sketch. 188.91KB
AVR DurAVR First In Human Patient 6 Month Study Follow UpPRICE SENSITIVE21/06/22 download Created with Sketch. 166.17KB
AVR Successful Completion of Second First-In-Human StudyPRICE SENSITIVE31/05/22 download Created with Sketch. 168.24KB
AVR EXPANSION OF FIRST IN HUMAN TRIALPRICE SENSITIVE25/05/22 download Created with Sketch. 207.03KB
AVR AGM Chairman Address and CEO PresentationPRICE SENSITIVE25/05/22 download Created with Sketch. 14.92MB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE21/04/22 download Created with Sketch. 313.33KB
AVR USD 20M Placement - Perceptive AdvisorsPRICE SENSITIVE02/03/22 download Created with Sketch. 146.86KB
AVR Trading HaltPRICE SENSITIVE01/03/22 download Created with Sketch. 222.28KB
AVR Preliminary Final ReportPRICE SENSITIVE25/02/22 download Created with Sketch. 1.16MB
AVR Merger Proposal UpdatePRICE SENSITIVE15/02/22 download Created with Sketch. 164.83KB
AVR Proposal to Negotiate Non-Binding Letter of Intent - MergerPRICE SENSITIVE08/02/22 download Created with Sketch. 147.82KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE27/01/22 download Created with Sketch. 330.46KB
AVR Successful Interim Results for the First-In-Human TrialPRICE SENSITIVE24/01/22 download Created with Sketch. 214.96KB
AVR Underwriting Agreement - AVRO Listed OptionsPRICE SENSITIVE07/12/21 download Created with Sketch. 160.86KB
AVR Trading HaltPRICE SENSITIVE06/12/21 download Created with Sketch. 224.09KB
AVR Five TAVR Patients Successfully Implanted With DurAVR ValvePRICE SENSITIVE22/11/21 download Created with Sketch. 170.89KB
AVR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/10/21 download Created with Sketch. 383.94KB
AVR Results for the Second Quarter of 2025
12/08/25PRICE SENSITIVE download Created with Sketch. 280.95KB
AVR Quarterly Results Announcement and SEC Form 10-Q
12/08/25PRICE SENSITIVE download Created with Sketch. 957.73KB
AVR Results for the First Quarter of 2025
14/05/25PRICE SENSITIVE download Created with Sketch. 272.75KB
AVR Quarterly Results Announcement and SEC Form 10-Q
14/05/25PRICE SENSITIVE download Created with Sketch. 635.04KB
AVR SEC Form 10-K/A
30/04/25PRICE SENSITIVE download Created with Sketch. 469.48KB
AVR Anteris Reports One-Year Patient Outcomes for DurAVR THV
21/03/25PRICE SENSITIVE download Created with Sketch. 262.29KB
AVR 2024 Financial Results and Corporate Update
13/03/25PRICE SENSITIVE download Created with Sketch. 301.88KB
AVR Annual Report to shareholders
13/03/25PRICE SENSITIVE download Created with Sketch. 1.39MB
AVR Director Appointment/Resignation
06/03/25PRICE SENSITIVE download Created with Sketch. 212.79KB
AVR Partial Exercise of Option and End of Stabilisation Period
15/01/25PRICE SENSITIVE download Created with Sketch. 172.76KB
AVR Closing of US IPO, NASDAQ listing, ASX Listing of CDIs
17/12/24PRICE SENSITIVE download Created with Sketch. 173.8KB
AVR Reinstatement to Quotation
17/12/24PRICE SENSITIVE download Created with Sketch. 518.55KB
AVR ATGC Announces Pricing of US Initial Public Offering
13/12/24PRICE SENSITIVE download Created with Sketch. 177.73KB
AVR Confirmation of Implementation Timetable
13/12/24PRICE SENSITIVE download Created with Sketch. 170.59KB
AVR ATGC Announces Launch of U.S. Initial Public Offering
10/12/24PRICE SENSITIVE download Created with Sketch. 178.14KB
AVR Suspension from Quotation
05/12/24PRICE SENSITIVE download Created with Sketch. 262.04KB
AVR ATGC files Registration Statement for Proposed US IPO
25/11/24PRICE SENSITIVE download Created with Sketch. 183.26KB
AVR Approval-Supplementary Scheme Booklet, New Schemes Timetable
12/11/24PRICE SENSITIVE download Created with Sketch. 793.24KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24PRICE SENSITIVE download Created with Sketch. 381.03KB
AVR Anteris Secures Bridging Facility
31/10/24PRICE SENSITIVE download Created with Sketch. 265.07KB
AVR Update on Schemes, Nasdaq listing and US IPO
30/09/24PRICE SENSITIVE download Created with Sketch. 249.98KB
AVR Court Approval to Hold Scheme Meetings & Booklet Registered
02/09/24PRICE SENSITIVE download Created with Sketch. 3.76MB
AVR Half Yearly Report and Accounts
22/08/24PRICE SENSITIVE download Created with Sketch. 1.11MB
AVR Plan to Pursue Re-domiciliation, Nasdaq listing and US IPO
13/08/24PRICE SENSITIVE download Created with Sketch. 869.43KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24PRICE SENSITIVE download Created with Sketch. 365.33KB
AVR Capital Raise
24/07/24PRICE SENSITIVE download Created with Sketch. 7.17MB
AVR Trading Halt
22/07/24PRICE SENSITIVE download Created with Sketch. 564.8KB
AVR Pause in trading
22/07/24PRICE SENSITIVE download Created with Sketch. 115.09KB
AVR Anteris and v2vmedtech Announce Concept Lock for VClip
01/07/24PRICE SENSITIVE download Created with Sketch. 183.16KB
AVR AGM Chairman and CEO Presentation
29/05/24PRICE SENSITIVE download Created with Sketch. 7.14MB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
18/04/24PRICE SENSITIVE download Created with Sketch. 362.14KB
AVR Capital Raise
10/04/24PRICE SENSITIVE download Created with Sketch. 138.25KB
AVR Trading Halt
09/04/24PRICE SENSITIVE download Created with Sketch. 286.67KB
AVR Pause in trading
09/04/24PRICE SENSITIVE download Created with Sketch. 116.02KB
AVR Updated 30-day DurAVR THV Clinical Data
12/03/24PRICE SENSITIVE download Created with Sketch. 195.95KB
AVR Preliminary Final Report
28/02/24PRICE SENSITIVE download Created with Sketch. 1.29MB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24PRICE SENSITIVE download Created with Sketch. 352.81KB
AVR Investor Presentation
09/01/24PRICE SENSITIVE download Created with Sketch. 2.53MB
AVR Update on Equity Raising
15/12/23PRICE SENSITIVE download Created with Sketch. 176.71KB
AVR 30-day Haemodynamic Results from the DurAVR US EFS Trial
21/11/23PRICE SENSITIVE download Created with Sketch. 231.09KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23PRICE SENSITIVE download Created with Sketch. 338.86KB
AVR Reinstatement to Official Quotation
26/10/23PRICE SENSITIVE download Created with Sketch. 86.42KB
AVR Capital Raise
26/10/23PRICE SENSITIVE download Created with Sketch. 209.83KB
AVR Positive Results from Interim Analysis of DurAVR EFS Trial
25/10/23PRICE SENSITIVE download Created with Sketch. 239.22KB
AVR Suspension from Official Quotation
25/10/23PRICE SENSITIVE download Created with Sketch. 594.08KB
AVR Trading Halt
23/10/23PRICE SENSITIVE download Created with Sketch. 613.94KB
AVR Anteris Completes DurAVR THV EFS Enrolment
17/10/23PRICE SENSITIVE download Created with Sketch. 232.36KB
AVR Appendix 4D and Half Year Financial Report Announcement
25/08/23PRICE SENSITIVE download Created with Sketch. 182.9KB
AVR Appendix 4D and Half Year Financial Report
25/08/23PRICE SENSITIVE download Created with Sketch. 714.97KB
AVR Exceptional Results in Second Valve-in-Valve Case
14/08/23PRICE SENSITIVE download Created with Sketch. 145.89KB
AVR Commencement of American Depository Receipt Program
09/08/23PRICE SENSITIVE download Created with Sketch. 164.44KB
AVR Montefiore enrolls Patients in US Early Feasibility Study
09/08/23PRICE SENSITIVE download Created with Sketch. 208.28KB
AVR DurAVR first successful implantation Valve-in-Valve
31/07/23PRICE SENSITIVE download Created with Sketch. 155.23KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23PRICE SENSITIVE download Created with Sketch. 305.43KB
AVR Latest Patient Group Show Best Results to Date at 30 Days
13/06/23PRICE SENSITIVE download Created with Sketch. 177.4KB
AVR DurAVR THV Demonstrate Sustained Haemodynamics to 1 Year
09/06/23PRICE SENSITIVE download Created with Sketch. 177.46KB
AVR DurAVR Maintains Exceptional Results in New Patient Cohort
31/05/23PRICE SENSITIVE download Created with Sketch. 151.62KB
AVR AGM Chairman Address and CEO Presentation
29/05/23PRICE SENSITIVE download Created with Sketch. 8MB
AVR FIH Results Presented at EuroPCR & Simultaneous Publication
22/05/23PRICE SENSITIVE download Created with Sketch. 171.97KB
AVR Additional Patent for Heart Valve Replacement Technology
17/05/23PRICE SENSITIVE download Created with Sketch. 189.9KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
24/04/23PRICE SENSITIVE download Created with Sketch. 285.17KB
AVR Agreement to Develop New Heart Valve Repair Device
19/04/23PRICE SENSITIVE download Created with Sketch. 233.95KB
AVR Patent for Transcatheter Heart Valve Replacement Technology
12/04/23PRICE SENSITIVE download Created with Sketch. 142.14KB
AVR Presentation at NWR Virtual Healthcare Conference
21/03/23PRICE SENSITIVE download Created with Sketch. 3.68MB
AVR S&P DJI Announces March 2023 Quarterly Rebalance
03/03/23PRICE SENSITIVE download Created with Sketch. 128.97KB
AVR Preliminary Final Report
28/02/23PRICE SENSITIVE download Created with Sketch. 1.98MB
AVR Settlement of $35M Capital Raising Transaction
15/02/23PRICE SENSITIVE download Created with Sketch. 197.59KB
AVR FDA Grants Expanded Approval for the DurAVR EFS
09/02/23PRICE SENSITIVE download Created with Sketch. 193.17KB
AVR $35M Capital Raise
09/02/23PRICE SENSITIVE download Created with Sketch. 167.64KB
AVR Trading Halt
07/02/23PRICE SENSITIVE download Created with Sketch. 239.32KB
AVR Pause in Trading
07/02/23PRICE SENSITIVE download Created with Sketch. 116.79KB
AVR Proposed $50 Million Capital Facility
06/02/23PRICE SENSITIVE download Created with Sketch. 242.67KB
AVR Trading Halt
02/02/23PRICE SENSITIVE download Created with Sketch. 598.29KB
AVR Pause in Trading
02/02/23PRICE SENSITIVE download Created with Sketch. 116.09KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23PRICE SENSITIVE download Created with Sketch. 290.43KB
AVR DurAVR First in Human Study 12 Month Results
16/01/23PRICE SENSITIVE download Created with Sketch. 185.98KB
AVR FDA Approves Early Feasibility Study for DurAVR THV System
28/11/22PRICE SENSITIVE download Created with Sketch. 171.92KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
26/10/22PRICE SENSITIVE download Created with Sketch. 319.67KB
AVR Results Demonstrating Restoration of Normal Pre-Disease Flow
19/09/22PRICE SENSITIVE download Created with Sketch. 165.97KB
AVR Appendix 4D and Half Year Financial Report Announcement
24/08/22PRICE SENSITIVE download Created with Sketch. 174.21KB
AVR Appendix 4D and Half Year Financial Report
24/08/22PRICE SENSITIVE download Created with Sketch. 620.54KB
AVR Appendix 4C Clarification and Upcoming Milestones
27/07/22PRICE SENSITIVE download Created with Sketch. 176.33KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
25/07/22PRICE SENSITIVE download Created with Sketch. 317.11KB
AVR Update on First In Human DurAVR THV Study
11/07/22PRICE SENSITIVE download Created with Sketch. 188.91KB
AVR DurAVR First In Human Patient 6 Month Study Follow Up
21/06/22PRICE SENSITIVE download Created with Sketch. 166.17KB
AVR Successful Completion of Second First-In-Human Study
31/05/22PRICE SENSITIVE download Created with Sketch. 168.24KB
AVR EXPANSION OF FIRST IN HUMAN TRIAL
25/05/22PRICE SENSITIVE download Created with Sketch. 207.03KB
AVR AGM Chairman Address and CEO Presentation
25/05/22PRICE SENSITIVE download Created with Sketch. 14.92MB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
21/04/22PRICE SENSITIVE download Created with Sketch. 313.33KB
AVR USD 20M Placement - Perceptive Advisors
02/03/22PRICE SENSITIVE download Created with Sketch. 146.86KB
AVR Trading Halt
01/03/22PRICE SENSITIVE download Created with Sketch. 222.28KB
AVR Preliminary Final Report
25/02/22PRICE SENSITIVE download Created with Sketch. 1.16MB
AVR Merger Proposal Update
15/02/22PRICE SENSITIVE download Created with Sketch. 164.83KB
AVR Proposal to Negotiate Non-Binding Letter of Intent - Merger
08/02/22PRICE SENSITIVE download Created with Sketch. 147.82KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
27/01/22PRICE SENSITIVE download Created with Sketch. 330.46KB
AVR Successful Interim Results for the First-In-Human Trial
24/01/22PRICE SENSITIVE download Created with Sketch. 214.96KB
AVR Underwriting Agreement - AVRO Listed Options
07/12/21PRICE SENSITIVE download Created with Sketch. 160.86KB
AVR Trading Halt
06/12/21PRICE SENSITIVE download Created with Sketch. 224.09KB
AVR Five TAVR Patients Successfully Implanted With DurAVR Valve
22/11/21PRICE SENSITIVE download Created with Sketch. 170.89KB
AVR Quarterly Activities/Appendix 4C Cash Flow Report
28/10/21PRICE SENSITIVE download Created with Sketch. 383.94KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$5.60
Change
0.330(6.26%)
Mkt cap ! $86.68M
Open High Low Value Volume
$5.50 $5.60 $5.30 $89.45K 16.14K

Buyers (Bids)

No. Vol. Price($)
1 103 $5.30
 

Sellers (Offers)

Price($) Vol. No.
$5.98 992 1
View Market Depth
Last trade - 15.29pm 22/08/2025 (20 minute delay) ?
Last
$5.59
  Change
0.330 ( 4.68 %)
Open High Low Volume
$5.59 $5.59 $5.29 3526
Last updated 15.28pm 22/08/2025 ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.